The renewed work aims to complete the university’s 5,300-square-metre Laboratory Complex, a project that began in 2014 but stalled for several years.
Under the terms of the agreement, Lilly will pay US$6.75 per share in cash, representing a 40% premium over AtaiBeckley’s 30-day volume-weighted average share price.
Following the transaction, former Kira shareholders will own nearly 50% of the combined company, new private financing investors will hold slightly more than 43%, and existing Jasper shareholders will retain almost 7%.
The proposed Biotech Life Sciences Park will undergo a feasibility study after APIFA Biotech’s privately initiated proposal received approval to advance to the project development stage under a public-private partnership (PPP) arrangement.
The Georgetown facility includes a payload operations control center that allows Redwire to monitor and manage experiments conducted in real time aboard the International Space Station (ISS).
The latest investment represents the next phase in the long-term development of the Kemnath site, which plays a significant role in the company’s manufacturing operations.
The partnership brings together PureHealth’s expertise in healthcare and health longevity science with Aldar’s experience in developing integrated, people-centred master-planned communities.
Although Tanzania has not reported any confirmed Ebola cases, the government continues to enhance preparedness measures through its national contingency plans.
Khansaheb Investment LLC will transfer its 55 per cent stake, while Clemenceau Medical Company S.A.E.M.L. will sell its 25 per cent holding.
The BD-Ebov trial, which is being conducted in Oxford, will evaluate the safety, tolerability and immune response of the ChAdOx1 BDBV vaccine in 50 healthy adults aged between 18 and 55 years.